Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs

Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs

Objectives This study aimed to determine the immunogenicity and the influence on disease activity of an adjuvanted recombinant varicella-zoster virus (VZV) subunit vaccine (RZV) in patients with rheumatoid arthritis (RA) treated with disease-modifying antirheumatic drugs (DMARDs).Methods This prospe...

Full description

Bibliographic Details
Main Authors: Kei Ikeda, Taro Iwamoto, Shunsuke Furuta, Hiroshi Nakajima, Yoshihisa Kobayashi, Shotaro Kojima, Arifumi Iwata, Tomoaki Ida, Manami Kato, Fumiyoshi Takizawa, Junya Suzuki, Yosuke Toda, Kazusa Miyachi
Format: Article
Language:English
Published: BMJ Publishing Group 2024-02-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/10/1/e003902.full

Internet

https://rmdopen.bmj.com/content/10/1/e003902.full

Similar Items